- NOK5.14bn
- NOK5.07bn
- NOK699.77m
Brief: Medistim Q2 EBIT NOK 42.2 Million
Brief: Medistim Announces Partnership With Cardiac Surgery Trial Dedicated To Women
Brief: Medistim Posts Q1 EBIT of NOK 33.5 Million
Brief: Medistim Opens Direct Sales Office In China
Brief: Medistim Q4 EBIT Up At NOK 36.5 Mln
Brief: Medistim Q4 EBIT at NOK 36.5 Million
Brief: Medistim Transfers 12,000 Shares To Co's CEO Kari E. Krogstad
Brief: Medistim Q3 EBIT Rises To NOK 34.0 mln
Brief: Medistim Q2 EBIT Falls To NOK 37.4 Mln
Brief: Medistim Q2 EBIT Rises To NOK 42.7 Million
Brief: S&T Sells 10% Stake In Medistim To Aeternum Capital
Brief: Medistim Q4 EBIT Up At NOK 22.1 Mln
Brief: Medistim Partners With LivaNova As Their New Distributor For India
Brief: Medistim ASA Q3 Sales Nok 83.4 Million
Brief: Medistim Q2 EBIT Down At NOK 27.7 Mln
Brief: Medistim CFO Thomas Jakobsen Sells Shares In Co
Brief: Medistim Q1 EBIT Rises To NOK 24.8 Mln
Brief: Medistim: Change Of Dividend Proposal For FY 2019
Brief: Fund Managed By ODIN Forvaltning Byus 9.82% Stake In Medistim